Reference : New insights into the complex role of mitochondria in Parkinson's disease
Scientific journals : Article
Life sciences : Biochemistry, biophysics & molecular biology
Systems Biomedicine
New insights into the complex role of mitochondria in Parkinson's disease
Grünewald, Anne mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Kumar, Kishore R mailto []
Sue, Carolyn M mailto []
Progress in Neurobiology
United Kingdom
[en] Mitochondria ; Parkinson's disease
[en] New discoveries providing insights into mitochondrial bioenergetics, their dynamic interactions as well as their role in cellular homeostasis have dramatically advanced our understanding of the neurodegenerative process of Parkinson's disease (PD). Respiratory chain impairment is a key feature in sporadic PD patients and there is growing evidence that links proteins encoded by PD-associated genes to disturbances in mitochondrial function. Against the backdrop of latest advances in the development of PD treatments that target mitochondria, we aim to give an overview of the literature published in the last three decades on the significance of mitochondria in the pathogenesis of PD. We describe the contribution of mitochondrial genome alterations and PD-associated genes to mitochondrial maintenance. We highlight mitophagy as a key mechanism in neurodegeneration. Moreover, we focus on the reciprocal interaction between alpha-synuclein aggregation and mitochondrial dysfunction. We discuss a novel trafficking pathway involving mitochondrial-derived vesicles within the context of PD and provide a synopsis of the most recently emerging topics in PD research with respect to mitochondria. This includes the relationship between mitochondria and cell-mediated immunity, the ER-mitochondria axis, sirtuin-mediated mitochondrial stress response and the role of micro RNAs in the aetiology of PD. In addition, recent studies have challenged the neuro-centric view of PD pathology, moving microglia and astrocytes into the research spotlight. Greater insights into these mechanisms may hold the key for the development of novel targeted therapies, addressing the need for a disease-modifying treatment, which has remained elusive to date.
Luxembourg Centre for Systems Biomedicine (LCSB): Molecular and Functional Neurobiology (Grünewald Group)
Fonds National de la Recherche - FnR ; German Research Foundation - DFG
FnR ; FNR9631103 > Anne Gr�newald > Model IPD > Modelling idiopathic Parkinson�s disease-associated somatic variation in dopaminergic neurons > 01/01/2016 > 31/12/2020 > 2015

File(s) associated to this reference

Fulltext file(s):

Open access
Grünewald.ProgNeurobiol.2019.mitoreview.pdfPublisher postprint4.73 MBView/Open

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.